Article

Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approach

2023-01-04

Abstract excerpt

With the ongoing evolution of the SARS-CoV-2 virus, variant-adapted vaccines are likely to be required. Given the challenges of conducting clinical trials against a background of widespread infection-induced immunity, updated vaccines are likely to be adopted based on immunogenicity data. We extended a modelling framework linking immunity levels and protection and fitted the model to vaccine effectiveness data fro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 479aeb8a-b9c9-50b8-a45f-92af50742773
DOI: 10.1101/2023.01.03.23284131

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approachDOI 10.1101/2023.01.03.23284131Read

Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5Semantic proximity Read

Expert Review of Global Real-World Vaccine Effectiveness Against SARS-CoV-2Semantic proximity Read

Validation of neutralizing antibody titers for estimating vaccine effectiveness for the Omicron SARS-CoV-2 variant, BA.1Semantic proximity Read

Long Term Vaccination Strategies to Mitigate the Global Impact of SARS-CoV-2 Transmission: A Modelling StudySemantic proximity Read

The Effectiveness of COVID-19 Vaccination in a Regional PopulationSemantic proximity Read

Comparative effectiveness of different primary vaccination courses on mRNA based booster vaccines against SARs-COV-2 infections: A time-varying cohort analysis using trial emulation in the Virus Watch community cohortSemantic proximity Read

Predicting immune protection against outcomes of infectious disease from population-level effectiveness data with application to COVID-19Semantic proximity Read

Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpointSemantic proximity Read

The value of vaccine booster doses to mitigate the global impact of the Omicron SARS-CoV-2 variantSemantic proximity Read

Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalisation: a systematic review and meta-analysisSemantic proximity Read

COVID-19 Vaccine Effectiveness against the Omicron BA.2 variant in EnglandSemantic proximity Read

Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in FranceSemantic proximity Read